Luminopia

Biotechnology ResearchMassachusetts, United States11-50 Employees

Luminopia is a small biotechnology company pursuing a new class of digital therapies for neuro-visual disorders, with a lead product targeting pediatric amblyopia. The therapies are developed to be rigorously evaluated for FDA approval while remaining engaging and usable for patients. The company partners with Boston Children's Hospital as an Innovation Partner to advance its amblyopia program.

Based in Cambridge, Massachusetts, Luminopia sits within the biotechnology research industry. Its target customers include children affected by amblyopia and the clinicians who treat them, addressing the condition that is a leading cause of vision loss in youth. In June 2026, Luminopia announced its first international expansion via a licensing agreement with ROHTO Pharmaceutical to bring its pediatric amblyopia treatment to Japan.

Sign up for free to view info

Email Format Employee directory